Hypermethylation of the RASSF1 promoter responsible for RASSF1A expression has a well-established role in tumor progression in several organ systems and tissue types[26,40-45], including several endocrine tumors. The gene discussed is RASSF1; the disease is malignant endocrine neoplasm.